MedTrace Logo

Tranexamic Acid in Pediatric Undergoing Proximal Femoral Osteotomies and/or Acetabular Osteotomy

NCT04811313 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 400

Last updated 2025-11-17

No results posted yet for this study

Summary

Surgical hip reconstruction reduces the hip joint through soft tissue releases and osteotomies of the femur and/or pelvis. Blood loss and subsequent blood transfusion are normal consequences of hip reconstruction.

Conditions

  • Intraoperative Blood Loss
  • Pediatric
  • Orthopedic Disorder

Interventions

DRUG

Tranexamic acid

patients treated with TXA will have reduced blood loss and transfusion requirements compared with those who did not receive TXA

PROCEDURE

caudal epidural block

regional anesthesia in orthopedic procedures are known to help reduction of intraoperative blood loss

OTHER

Placebo

participants will receive standard care but neither TXA nor caudal epidural block

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Amr M Sleem, M.D. · Assiut University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
1 Year
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-04-03
Primary Completion
2026-01-31
Completion
2026-03-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04811313 on ClinicalTrials.gov